A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients

Inclusion Criteria:

• OAB patients who present with OAB symptoms(≥8 micturitions and ≥3 urgency episodes per 24 h documented in the baseline bladder diary)

• OAB patients dissatisfied with their prior therapy with tolterodine

Exclusion Criteria:

• Patients with any contraindication to fesoterodine usage, e.g., urinary retention,gastric retention, uncontrolled narrow-angle glaucoma, or known hypersensitivity tothe drug or its ingredients.

• Patients with significant hepatic and renal disease or other significant unstablediseases.

• OAB symptoms caused by neurological conditions, known pathologies of urinary tract,etc.